Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting

August 8, 2017 updated by: Smith & Nephew, Inc.

A Non-Randomized, Prospective Study of Short Term Outcomes Following Total Knee Replacement With JOURNEY™ II BCS Total Knee System Compared to Other Posterior Stabilized Total Knee Systems in a Physical Therapy Setting

The primary objective of the study is to determine how the short-term outcome of subjects implanted with the JOURNEY™ II BCS Total Knee System compares to subjects implanted with other PS total knee systems, and to determine if there is a difference in health care resources consumed that may result in economic savings to patients, the facility and/or the payer.

To address the study objectives, patient self-assessment questionnaires, and other objective measures of post-operative function and health care resource utilization will be used for data collection.

Study Overview

Study Type

Observational

Enrollment (Actual)

22

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Annapolis, Maryland, United States, 21401
        • Anne Arundel Medical Cneter
    • Oregon
      • Eugene, Oregon, United States, 97401
        • Slocum Research & Educational Foundation
    • Pennsylvania
      • State College, Pennsylvania, United States, 16801
        • University Orthopaedic Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects who have a primary diagnosis of osteoarthritis, degenerative arthritis, or traumatic arthritis and who will receive either the Journey II BCS knee or any other posterior stabilized knee.

Description

Inclusion Criteria:

  • Undergone unilateral primary total knee replacement with a JOURNEY™ II BCS Total Knee System or other Non-Smith & Nephew Posterior Stabilized Knee System
  • Will be initiating outpatient PT ≤ 7 days post-operatively
  • Has a primary diagnosis of osteoarthritis, degenerative arthritis, or traumatic arthritis
  • Has pre-operative ROM ≥ 90°
  • Is skeletally mature in the PI judgment
  • Is 21 years of age of older
  • Is willing and able to participate in required follow-up visits at the study site and to complete study procedures and questionnaires
  • Has consented to participate in the study by signing the IRB/EC approved informed consent for the study
  • Agrees to follow post- operative physical therapy program

Exclusion Criteria:

  • Significant preoperative varus or valgus deformities (>15º)
  • Has received a constrained or deep dish tibial insert
  • Morbid obesity (BMI > 40)
  • Has not obtained required pre-rehabilitation, pre-operative and intra-operative records by week 2 visit
  • Other comorbidities that may impact outcomes such as osteoporosis, uncontrolled diabetes and active infection
  • Fibromyalgia requiring treatment
  • Current or impending incarceration or is a prisoner
  • In the opinion of the PI has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse
  • Is known to be at risk for lost to follow-up, or failure to return for scheduled visits
  • Undergone or is planning to undergo total knee replacement of the contralateral knee within 6 months of this total knee replacement
  • Requires a Legally Authorized Representative to consent to the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Journey II BCS Knee
Physical Therapy Observational
All Other Posterior Stabilized Knees
Physical Therapy Observational

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in Knee Range of Motion (ROM) at the first outpatient Physical Therapy (PT) visit (≤7 days of surgery) between the 2 treatment groups
Time Frame: ≤7 days of surgery
The absolute Range of Motion of index knee will be compared between groups
≤7 days of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Beate Hanson, MD, Smith & Nephew, Inc.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Actual)

April 27, 2017

Study Completion (Actual)

April 27, 2017

Study Registration Dates

First Submitted

June 29, 2016

First Submitted That Met QC Criteria

June 29, 2016

First Posted (Estimate)

July 1, 2016

Study Record Updates

Last Update Posted (Actual)

August 10, 2017

Last Update Submitted That Met QC Criteria

August 8, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Journey II BCS CMS Study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Study terminated therefore no data sharing planned

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Subscribe